Crystal structure of VioE, a key player in the construction of the molecular skeleton of violacein.
Violacein and the indolocarbazoles are naturally occurring bisindole products with various biological activities, including antitumor activity. Although these compounds have markedly different molecular skeletons, their biosynthetic pathways share the same intermediate "compound X," which is produced from L-tryptophan via indole-3-pyruvic acid imine. Compound X is a short-lived intermediate that is spontaneously converted to chromopyrrolic acid for indolocarbazole biosynthesis, whereas VioE transforms compound X into protodeoxyviolaceinic acid, which is further modified by other enzymes to produce violacein. Thus, VioE plays a key role in the construction of the molecular skeleton of violacein. Here, we present the crystal structure of VioE, which consists of two subunits, each of which forms a structure resembling a baseball glove. Each subunit has a positively charged pocket at the center of the concave surface of the structure. Mutagenesis analysis of the surface pocket and other surface residues showed that the surface pocket serves as an active site. We have also solved the crystal structure of a complex of VioE and phenylpyruvic acid as an analogue of a VioE-substrate complex. A docking simulation with VioE and the IPA imine dimer, which is proposed to be compound X, agreed with the results from the mutational analysis and the VioE-phenylpyruvic acid complex structure. Based on these results, we propose that VioE traps the highly reactive substrate within the surface pocket to suppress CPA formation and promote protodeoxyviolaceinic acid formation caused by proximity and orientation effects.
Hirano
Satoshi
S
Biometal Science Laboratory, RIKEN SPring-8 Center, Hyogo 679-5148, Japan.
Asamizu
Shumpei
S
Onaka
Hiroyasu
H
Shiro
Yoshitsugu
Y
Nagano
Shingo
S
D019943:Amino Acid Substitution; D000970:Antineoplastic Agents / Q000737:chemistry / Q000378:metabolism; D001426:Bacterial Proteins / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism; D001665:Binding Sites / Q000502:physiology; D002861:Chromobacterium / Q000201:enzymology* / Q000235:genetics; D018360:Crystallography, X-Ray; D019281:Dimerization; D007211:Indoles / Q000737:chemistry* / Q000378:metabolism; D016297:Mutagenesis, Site-Directed; D010088:Oxidoreductases / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism; D010667:Phenylpyruvic Acids / Q000737:chemistry* / Q000378:metabolism; D020836:Protein Structure, Quaternary / Q000502:physiology; D013499:Surface Properties; D014364:Tryptophan / Q000737:chemistry / Q000378:metabolism
D000970:Antineoplastic Agents; D001426:Bacterial Proteins; D007211:Indoles; D010667:Phenylpyruvic Acids; C008122:indol-3-yl pyruvic acid; D014364:Tryptophan; D010088:Oxidoreductases; C063155:violacein; C031606:phenylpyruvic acid